NGVT
Get informed when a big investor buys or sells
+ FollowOvervalued by 78.8% based on the discounted cash flow analysis.
| Market cap | $2.39 Billion |
|---|---|
| Enterprise Value | $3.49 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.61 |
| Beta | 1.18 |
| Outstanding Shares | 35,000,000 |
| P/E Ratio | 45.08 |
|---|---|
| PEG | -36.33 |
| Price to Sales | 2.12 |
| Price to Book Ratio | 69.83 |
| Enterprise Value to Revenue | 3.01 |
| Enterprise Value to EBIT | 45.62 |
| Enterprise Value to Net Income | 64 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 25.59 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 18.71% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 109.63%▲ 7.85% |
|---|---|
| Total Invested | $2.70B▲ 5.50% |
| Investors Holding | 314▲ 7.00% |
No data
Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect and enhance the world around us. Through a team of talented and experienced people, Ingevity develops, manufactures, an...